13-Aug-2026
TipRanks (Wed, 12-Aug 1:15 PM ET)
TipRanks (Wed, 12-Aug 7:50 AM ET)
TD Cowen Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)
TipRanks (Wed, 12-Aug 2:45 AM ET)
Biohaven: Broad Late-Stage Pipeline Supports Buy Rating and Unchanged $21 Price Target
TipRanks (Tue, 11-Aug 7:06 AM ET)
RBC Capital Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)
TipRanks (Tue, 11-Aug 6:46 AM ET)
Bank of America Securities Reaffirms Their Buy Rating on Biohaven Ltd. (BHVN)
TipRanks (Tue, 11-Aug 5:15 AM ET)
TipRanks (Tue, 11-Aug 4:10 AM ET)
Biohaven Non-GAAP EPS of -$0.78 misses by $0.17
Seeking Alpha News (Mon, 10-Aug 4:05 PM ET)
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
PRNewswire (Mon, 10-Aug 4:02 PM ET)
Biohaven Appoints Technology Investor John Yetimoglu to Board of Directors
PRNewswire (Thu, 6-Aug 7:00 AM ET)
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Biohaven Ltd. Common Shares trades on the NYSE stock market under the symbol BHVN.
As of August 13, 2026, BHVN stock price climbed to $14.85 with 1,533,033 million shares trading.
BHVN has a beta of 2.06, meaning it tends to be more sensitive to market movements. BHVN has a correlation of 0.07 to the broad based SPY ETF.
BHVN has a market cap of $2.24 billion. This is considered a Mid Cap stock.
In the last 3 years, BHVN traded as high as $62.21 and as low as $7.48.
The top ETF exchange traded funds that BHVN belongs to (by Net Assets): XBI, IWM, VXF, IWO, IBB.
BHVN has underperformed the market in the last year with a return of +3.2%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BHVN shares. However, BHVN has outperformed the market in the last 3 month and 2 week periods, returning +64.5% and +7.5%, while SPY returned +5.0% and +4.9%, respectively. This indicates BHVN has been having a stronger performance recently.
BHVN support price is $13.81 and resistance is $14.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHVN shares will trade within this expected range on the day.
